Primis Financial Corp. (NASDAQ: FRST) has announced a signed non-binding term sheet to sell a portion of its shares in Panacea Financial Holdings, Inc. This move is expected to generate approximately $22 million in proceeds for Primis and an additional pre-tax gain of between $6.5 and $7.0 million, as the sales price per share surpasses the carrying value as of March 31, 2025. The sale follows the deconsolidation of Panacea Financial Holdings earlier this year. Primis CEO Dennis J. Zember, Jr. highlighted that the proceeds will enable the company to pursue strategies such as a share repurchase program and accelerated growth initiatives. Despite the sale, Primis remains committed to Panacea's long-term potential and its mission to provide tech-enabled financial solutions for doctors nationwide.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。